Biotechnology
News Category
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes
MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, using voice analysis to detect...
Quantum BioPharma Showcases MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman appeared on the BioMedWire Podcast to discuss the company's lead MS drug candidate Lucid-MS and its alcohol ...
VERAXA Biotech's Antibody Platform Positions It for Strategic Partnerships Amid Strong Sector Deal Activity
The article highlights that VERAXA Biotech AG's technology platform in antibody-drug conjugates and T-cell engagers places it favorably for potential ...
Onco-Innovations Announces CAD$5 Million Private Placement Term Sheet for Oncology Programs
Onco-Innovations Limited executed a term sheet for a CAD$5 million non-brokered private placement to fund its ONC010 program and SynoGraph platform de...
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft
Onco-Innovations Limited initiates polymer process development with Nanosoft Polymers to establish a scalable, reproducible platform for its lead nano...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer Amid Pivotal Phase 3 Alzheimer’s Study
Annovis Bio promotes Dr. Cheng Fang to Chief Scientific Officer, positioning him to lead scientific strategy as the company approaches top-line data f...
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
GeoVax comments on recent U.S. government procurement of smallpox vaccine ACAM2000, reinforcing the strategic importance of sustained investment in or...
Active Hybrid Humidification Incubator Market Set to Surge to USD 229.2 Million by 2036, Driven by Advanced Cell Culture Demands
The active hybrid humidification incubator market is projected to grow from USD 90.0 million in 2026 to USD 229.2 million by 2036 at a 9.8% CAGR, driv...
Helix BioPharma Strengthens Executive Leadership Ahead of U.S. Listing and Clinical Advancement
Helix BioPharma appoints Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its planned U.S. exchange listi...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam (NASDAQ: BEAT) has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study for heart attack detection using its 3D ECG t...
Cardio Diagnostics Holdings Uses Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings (NASDAQ: CDIO) leverages epigenetic testing to reveal cardiovascular risks beyond traditional genetic markers, offering in...
Onco-Innovations Advances Manufacturing and Development of Novel PNKP Inhibitors for Hard-to-Treat Cancers
Onco-Innovations Ltd. is making progress in the development of PNKP inhibitors, a new class of DNA damage response therapies, with a key manufacturing...
TechForce Robotics Enters Pharmaceutical Automation with First Laboratory Robot Deployment
TechForce Robotics has deployed its LIM-E autonomous laboratory robot at Oncotelic Therapeutics, marking its expansion from hospitality into pharmaceu...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma's partner Resyca will conduct a robustness study on the nasal spray device for SPC-15, supporting regulatory guidance for Phase 1 trials a...
Creative Biolabs Offers Custom Oligosaccharide Synthesis and Glycan Characterization to Accelerate Drug Discovery
Creative Biolabs combines advanced synthesis and analytical platforms to provide structurally validated oligosaccharides, addressing challenges in gly...
Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development
Creative Enzymes' new AI-driven platform aims to cut enzyme development time in half and reduce costs by combining computational enzyme engineering wi...
Amerigo Scientific Launches High-Quality iPSC-Derived Cells to Boost Biomedical Research and Cell Therapy Development
Amerigo Scientific releases premium iPSC-derived cells and engineered reporter lines, offering robust tools for disease modeling, drug screening, and ...
Quantum BioPharma Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study
Quantum BioPharma's collaborative imaging study with Massachusetts General Hospital has reached the halfway point in patient enrollment, with early re...
Cardio Diagnostics Uses Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings leverages epigenetics to reveal cardiovascular risks beyond genetics, offering insights into lifestyle and environmental i...
SUIC and VisionRenu Sign Strategic MOU to Accelerate AI Biotechnology and U.S. Capital Market Expansion
SUIC Worldwide Holdings Ltd. and VisionRenu Biomedical Technology Co., Ltd. have signed a strategic MOU to collaborate on AI-powered biotechnology, pr...
Oncotelic Therapeutics Publishes Peer-Validation of Deciparticle Platform for Intravenous Drug Delivery
Oncotelic Therapeutics and Sapu Nano announced the publication of a peer-reviewed manuscript validating the Deciparticle nanoparticle platform, with i...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Trial of TNX-102 SL for Major Depressive Disorder
Tonix Pharmaceuticals has enrolled the first patient in its HORIZON Phase 2 trial evaluating TNX-102 SL as a first-line monotherapy for major depressi...
Xlife Sciences Shareholders Approve All Proposals at Annual General Meeting, Highlighting Key Milestones
Xlife Sciences AG shareholders approved all proposals at the Annual General Meeting, with Chairman David L. Deck emphasizing the Nasdaq listing of por...
Stonegate Capital Partners Initiates Coverage on OS Therapies, Highlighting Regulatory and Financial Milestones
Stonegate Capital Partners initiated coverage on OS Therapies, emphasizing the FDA's RMAT designation and BLA number for OST-HER2, promising Phase 2b ...
Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar for Reg D Offering
Quantum BioPharma's licensee, Unbuzzd Wellness, will hold an investor webinar on October 30 to discuss its Reg D 506(c) offering and up to $5 million ...
Pentixapharm Prioritizes Clinical Programs, Reduces Workforce by 50% to Extend Cash Runway
Pentixapharm is halting early-stage research and cutting half its workforce to focus on its Phase 3-ready CXCR4 program for hypertension diagnosis, ai...
Landmark MERLIN_001 Trial Shows Merlin CP-GEP Test Accurately Stratifies Melanoma Patients by Sentinel Node Metastasis Risk
The largest prospective study of a genomic test in cutaneous melanoma, published in JAMA Surgery, demonstrates that the Merlin CP-GEP Test can identif...
Lantern Pharma Partners with Hoth Therapeutics to Apply AI Platform PredictBBB.ai in Drug Development
Lantern Pharma's AI-powered PredictBBB.ai platform, with 94% accuracy in predicting blood-brain barrier penetration, is being deployed by Hoth Therape...
New LED Therapy Selectively Kills Cancer Cells While Sparing Healthy Tissue
Researchers have developed a new LED-based therapy that targets and destroys cancer cells without harming healthy cells, potentially reducing harsh si...
Nanomedicine Breakthrough Redefines Drug Delivery, Enhancing Bioavailability in Oncology
Nanomedicine advances, particularly Oncotelic Therapeutics' Deciparticle platform, are improving drug bioavailability and targeting, potentially trans...
Renaissance BioScience Named Among Canada's Top Food Technology Companies in Inaugural Foodtech Frontier Awards
Renaissance BioScience Corp. has been recognized as a rising star in Canada's food technology sector by the Canadian Food Innovation Network for its i...
GeoVax Highlights IDSA Guidance Underscoring Need for Tailored COVID-19 Vaccines for Immunocompromised Patients
GeoVax Labs emphasizes new IDSA guidelines that reveal current COVID-19 vaccines provide inadequate protection for immunocompromised individuals, vali...
Quantumzyme’s Participation at Enzyme Engineering XXVIII Highlights Advances in Sustainable Biocatalysis
Quantumzyme Corp. showcased its computational enzyme engineering innovations and a novel enzymatic ibuprofen synthesis pathway at the Enzyme Engineeri...
Oncotelic Therapeutics Featured in NetworkNewsWire Editorial on Nanomedicine Innovations in Oncology
Oncotelic Therapeutics highlights its Deciparticle platform in a NetworkNewsWire editorial, emphasizing how nanocarrier-based delivery systems are tra...
HeartBeam Partners with HeartNexus to Provide 24/7 Remote Cardiology Services and Real-Time ECG Interpretation
The partnership enables HeartBeam to offer round-the-clock cardiology reader services for patients using its 3D ECG technology, expanding access to re...
Nutriband Receives FDA Feedback Advancing AVERSA Fentanyl Toward NDA Submission
Nutriband's AVERSA Fentanyl, an abuse-deterrent transdermal system, moves closer to NDA submission after FDA confirms the 505(b)(2) regulatory pathway...
Glioblastoma Remission Rates Remain Low, Offering Little Hope for Patients
This article explains the low remission rates for glioblastoma, the most deadly primary brain cancer, and discusses factors influencing remission to h...
Soligenix Research Demonstrates High-Temperature Stability for Ebola and Marburg Vaccines, Addressing Critical Cold Chain Issues
Soligenix published peer-reviewed data showing its ThermoVax platform maintains stability for Ebola and Marburg vaccines at temperatures above 40°C, p...
NanoViricides CEO Highlights Potent Anti-Measles Results for NV-387 in Proactive Interview
NanoViricides' lead candidate NV-387 shows strong anti-measles activity in preclinical models, extending survival by 130% and protecting lung tissue, ...
Nanomedicine Advances Target Drug Delivery Challenges in Oncology
Innovations in nanocarrier-based drug delivery systems, such as Oncotelic Therapeutics' Deciparticle platform, are poised to improve bioavailability a...
Helix BioPharma Focuses on L-DOS47 Combination Therapy for NSCLC, Reports Reduced Net Loss for Fiscal 2025
Helix BioPharma Corp. reported a reduced net loss of $5.2 million for fiscal 2025, emphasizing a strategic shift to develop L-DOS47 in combination wit...
Oncotelic Therapeutics Highlighted in NetworkNewsWire Editorial on Nanomedicine Advances in Oncology
Oncotelic Therapeutics' Deciparticle platform is featured in a NetworkNewsWire editorial discussing how nanocarrier-based delivery systems are improvi...
GeoVax Urges Congress to Act After BIO CEO Warns U.S. Could Lose Biotech Leadership Within Two Years
GeoVax Labs responds to BIO CEO John Crowley's Senate testimony that U.S. biotech leadership could be overtaken by China within two years, calling for...
ABVC BioPharma Receives Additional $100,000 Licensing Payment from OncoX, Totaling $695,950
ABVC BioPharma's oncology partner OncoX made a fifth licensing payment in 2025, demonstrating cash flow visibility and advancing ABVC's licensing-driv...
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & Innovation
Quantumzyme Corp. announced the WIPO publication of its patent for enzymatic ibuprofen synthesis, strengthening its IP portfolio and advancing sustain...
ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025
ABVC BioPharma announced a 230% year-over-year increase in licensing revenue and a 181% expansion in total assets for Q3 2025, driven by strategic lan...
NanoViricides to Present at Spartan Capital Investor Conference 2025
NanoViricides will present at the Spartan Capital Investor Conference, highlighting its broad-spectrum antiviral drug NV-387 and other pipeline candid...
Sapu Nano Initiates First In-Human Clinical Trial of Sapu-003, an Injectable Everolimus Formulation
Sapu Nano has launched the first in-human clinical trial of Sapu-003, an injectable version of Everolimus (Afinitor) designed to improve bioavailabili...